---
source_path: R2405E-PDF-ENG.md
pages: n/a-n/a
chunk_id: a34a51f973c5c411670990644fe7c5a4595dcf77
title: R2405E-PDF-ENG
---
## from collaborations with entrepreneurial ventures. Two well-known

examples are the Pﬁzer-BioNTech Covid-19 mRNA vaccine and

Microsoft-backed OpenAI’s generative AI.

For these partnerships to work, incumbents need to create value for

the young companies—by, say, helping them test their inventions

or giving them access to their clients—and reserve the right to a

stake in any success. For instance, large ﬁrms might ask start-ups

to agree to become suppliers or secure the right of ﬁrst refusal on

investments. Smart incumbents typically pay start-ups for their services
